Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)
CNY 6.97
(-0.29%)
CNY 6.97
(-0.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.36 Billion CNY | -7.09% |
| 2022 | 2.45 Billion CNY | 26.29% |
| 2021 | 1.3 Billion CNY | 17.27% |
| 2020 | 1.63 Billion CNY | 59.75% |
| 2019 | 885.13 Million CNY | 396.66% |
| 2018 | -1.51 Billion CNY | -126.43% |
| 2017 | 1.2 Billion CNY | -26.68% |
| 2016 | 2.13 Billion CNY | 91.75% |
| 2015 | 1.87 Billion CNY | 49.47% |
| 2014 | 692.7 Million CNY | 223.14% |
| 2013 | 202.45 Million CNY | -23.1% |
| 2012 | 273.25 Million CNY | 9.05% |
| 2011 | 250.5 Million CNY | 7.67% |
| 2010 | 234.31 Million CNY | 31.53% |
| 2009 | 177.79 Million CNY | 26.83% |
| 2008 | 141.2 Million CNY | 9.31% |
| 2007 | 118.76 Million CNY | 68.09% |
| 2006 | 74.95 Million CNY | 0.47% |
| 2005 | 74.45 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 905.72 Million CNY | 54.52% |
| 2024 Q3 | 694.11 Million CNY | 9.19% |
| 2024 Q2 | 635.7 Million CNY | -27.09% |
| 2023 Q4 | 564.23 Million CNY | -22.08% |
| 2023 Q3 | 724.1 Million CNY | 22.07% |
| 2023 Q2 | 593.18 Million CNY | -27.82% |
| 2023 FY | - CNY | -7.09% |
| 2023 Q1 | 821.77 Million CNY | 48.52% |
| 2022 Q2 | 578.56 Million CNY | -18.25% |
| 2022 FY | - CNY | 26.29% |
| 2022 Q4 | 553.31 Million CNY | -14.53% |
| 2022 Q1 | 707.69 Million CNY | 105.86% |
| 2022 Q3 | 647.38 Million CNY | 11.9% |
| 2021 FY | - CNY | 17.27% |
| 2021 Q2 | 545.47 Million CNY | 5.61% |
| 2021 Q1 | 516.51 Million CNY | 26.54% |
| 2021 Q4 | 343.77 Million CNY | -37.56% |
| 2021 Q3 | 550.6 Million CNY | 0.94% |
| 2020 FY | - CNY | 59.75% |
| 2020 Q4 | 408.17 Million CNY | -6.23% |
| 2020 Q1 | 376.91 Million CNY | 80.74% |
| 2020 Q2 | 436.67 Million CNY | 15.85% |
| 2020 Q3 | 435.29 Million CNY | -0.31% |
| 2019 Q1 | 244.11 Million CNY | 827.7% |
| 2019 FY | - CNY | 396.66% |
| 2019 Q4 | 208.53 Million CNY | -11.68% |
| 2019 Q3 | 236.11 Million CNY | -19.78% |
| 2019 Q2 | 294.32 Million CNY | 20.57% |
| 2018 Q1 | 1 Billion CNY | 43.4% |
| 2018 Q3 | -1.02 Billion CNY | -91.81% |
| 2018 Q2 | -535.89 Million CNY | -153.21% |
| 2018 Q4 | 26.31 Million CNY | 102.56% |
| 2018 FY | - CNY | -126.43% |
| 2017 Q4 | 702.29 Million CNY | 135.94% |
| 2017 Q2 | 681.6 Million CNY | 502.57% |
| 2017 Q1 | 113.11 Million CNY | -93.37% |
| 2017 FY | - CNY | -26.68% |
| 2017 Q3 | 297.66 Million CNY | -56.33% |
| 2016 Q2 | 383.44 Million CNY | 113.0% |
| 2016 Q3 | -136.99 Million CNY | -135.73% |
| 2016 Q4 | 1.7 Billion CNY | 1346.25% |
| 2016 FY | - CNY | 91.75% |
| 2016 Q1 | 180.02 Million CNY | -80.77% |
| 2015 Q3 | 278.65 Million CNY | -49.6% |
| 2015 Q4 | 936.37 Million CNY | 236.03% |
| 2015 Q2 | 552.87 Million CNY | 395.22% |
| 2015 Q1 | -187.27 Million CNY | -170.06% |
| 2015 FY | - CNY | 49.47% |
| 2014 Q1 | 85.58 Million CNY | 2786.3% |
| 2014 Q3 | 139.41 Million CNY | 3.7% |
| 2014 FY | - CNY | 223.14% |
| 2014 Q4 | 267.31 Million CNY | 91.74% |
| 2014 Q2 | 134.44 Million CNY | 57.09% |
| 2013 Q4 | 2.96 Million CNY | -96.18% |
| 2013 FY | - CNY | -23.1% |
| 2013 Q3 | 77.57 Million CNY | -7.99% |
| 2013 Q2 | 84.31 Million CNY | 216.94% |
| 2013 Q1 | 26.6 Million CNY | -73.63% |
| 2012 Q1 | 21.74 Million CNY | -72.01% |
| 2012 Q2 | 52.34 Million CNY | 140.67% |
| 2012 Q3 | 85.95 Million CNY | 64.22% |
| 2012 Q4 | 100.87 Million CNY | 17.36% |
| 2012 FY | - CNY | 9.05% |
| 2011 Q3 | 67.97 Million CNY | 0.26% |
| 2011 Q2 | 67.79 Million CNY | 177.15% |
| 2011 Q1 | 24.46 Million CNY | -69.43% |
| 2011 FY | - CNY | 7.67% |
| 2011 Q4 | 77.7 Million CNY | 14.32% |
| 2010 Q3 | 57.84 Million CNY | -1.29% |
| 2010 FY | - CNY | 31.53% |
| 2010 Q2 | 58.59 Million CNY | 118.03% |
| 2010 Q1 | 26.87 Million CNY | -62.83% |
| 2010 Q4 | 80.02 Million CNY | 38.36% |
| 2009 Q1 | 22.65 Million CNY | 2.66% |
| 2009 Q3 | 26.73 Million CNY | -35.25% |
| 2009 Q4 | 72.3 Million CNY | 170.5% |
| 2009 FY | - CNY | 26.83% |
| 2009 Q2 | 41.28 Million CNY | 82.25% |
| 2008 FY | - CNY | 9.31% |
| 2008 Q4 | 22.06 Million CNY | -9.96% |
| 2008 Q3 | 24.5 Million CNY | -32.65% |
| 2008 Q2 | 36.38 Million CNY | -11.26% |
| 2008 Q1 | 41 Million CNY | 59.22% |
| 2007 FY | - CNY | 68.09% |
| 2007 Q1 | 35.64 Million CNY | 0.0% |
| 2007 Q3 | 24.93 Million CNY | -3.14% |
| 2007 Q4 | 25.75 Million CNY | 3.27% |
| 2007 Q2 | 25.74 Million CNY | -27.78% |
| 2006 FY | - CNY | 0.47% |
| 2005 FY | - CNY | 0.0% |